Understanding how Lyme disease bacteria control their infection processes
SpoVG and PlzA Regulation of Lyme Disease Spirochete Infection Processes
This study is looking at how the bacteria that cause Lyme disease manage their proteins to help them infect people, focusing on a specific protein called SpoVG, with the goal of finding new ways to treat and prevent Lyme disease for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10597629 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the Lyme disease-causing bacteria, Borrelia burgdorferi, regulate their proteins during infection. By studying a specific protein called SpoVG, which plays a crucial role in the bacteria's ability to infect hosts, the research aims to uncover new targets for therapies. The project involves examining how these bacteria respond to signals from their environment, which could lead to improved treatments for Lyme disease. The findings could help in developing better preventative measures and curative options for patients suffering from this infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Lyme disease or those at high risk of infection.
Not a fit: Patients who have already been effectively treated for Lyme disease and are not experiencing any ongoing symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Lyme disease, reducing the risk of long-term health complications.
How similar studies have performed: Previous research has shown promise in understanding bacterial infection mechanisms, suggesting that this approach could yield valuable insights.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Stevenson, Brian — University of Kentucky
- Study coordinator: Stevenson, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.